August 26, 2014
1 min read
Save

Advances in imaging technologies improve screening, detection of diabetic eye disease

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

For years, the main reason for ophthalmic screening in patients with diabetes has been to detect the presence of diabetic retinopathy or diabetic macular edema — both of which may lead to blindness if untreated — relying on either a dilated fundus examination or color photography.

One expert estimated that a dilated fundus examination performed by an ophthalmologist detects diabetic retinopathy in more than 90% of cases. Even so, subtle diabetic macular edema may not be picked up without an optical coherence tomography examination, according to David M. Brown, MD, FACS, of Retina Consultants of Houston.

David Brown

David M. Brown

 

“In 30% of cases of diabetic macular edema, you will miss it without either a good exam or an OCT,” Brown said.

Even as a growing number of clinicians are enthusiastically adopting photographic screening programs for diabetic retinopathy, these programs “are not considered a replacement for a comprehensive eye evaluation by an ophthalmologist experienced in managing diabetic retinopathy,” according to the American Academy of Ophthalmology Preferred Practice Pattern. 

Click here to read the full cover story published in Ocular Surgery News U.S. Edition.